Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

49 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Estimating Cancer Screening Sensitivity and Specificity Using Healthcare Utilization Data: Defining the Accuracy Assessment Interval.
Chubak J, Burnett-Hartman AN, Barlow WE, Corley DA, Croswell JM, Neslund-Dudas C, Vachani A, Silver MI, Tiro JA, Kamineni A. Chubak J, et al. Among authors: silver mi. Cancer Epidemiol Biomarkers Prev. 2022 Aug 2;31(8):1517-1520. doi: 10.1158/1055-9965.EPI-22-0232. Cancer Epidemiol Biomarkers Prev. 2022. PMID: 35916602 Free PMC article.
Characteristics of Clinicians Caring for Transgender Men and Nonbinary Individuals and Guideline Concordance of Clinicians' Cervical Cancer Screening Counseling for Cisgender Individuals Versus Transgender Men and Nonbinary Individuals with a Cervix.
McDowell A, Rieu-Werden ML, Atlas SJ, Fields CD, Goldstein RH, Gundersen GD, Haas JS, Higashi RT, Pruitt SL, Silver MI, Tiro JA, Kamineni A. McDowell A, et al. Among authors: silver mi. LGBT Health. 2024 Oct;11(7):563-569. doi: 10.1089/lgbt.2023.0067. Epub 2024 Apr 22. LGBT Health. 2024. PMID: 38648535
Assessing Management of Abnormal Cervical Cancer Screening Results and Concordance with Guideline Recommendations in Three US Healthcare Settings.
Cheng D, Rieu-Werden ML, Lykken JM, Werner CL, Feldman S, Silver MI, Atlas SJ, Tiro JA, Haas JS, Kamineni A. Cheng D, et al. Among authors: silver mi. Cancer Epidemiol Biomarkers Prev. 2024 Jul 1;33(7):912-922. doi: 10.1158/1055-9965.EPI-23-1564. Cancer Epidemiol Biomarkers Prev. 2024. PMID: 38652505 Free PMC article.
Clinician-perceived barriers to cervical cancer screening before and during the COVID-19 pandemic at three US healthcare systems.
Boratyn VM, Pocobelli G, Atlas SJ, Clark CR, Feldman S, Kruse G, Marie McCarthy A, Rieu-Werden M, Silver MI, Santini NO, Tiro JA, Haas JS. Boratyn VM, et al. Among authors: silver mi. Prev Med Rep. 2024 Jun 1;43:102783. doi: 10.1016/j.pmedr.2024.102783. eCollection 2024 Jul. Prev Med Rep. 2024. PMID: 38883925 Free PMC article.
Association Between Clinician Confidence and Making Guideline-Recommended Decisions in the Management of Abnormal Cervical Cancer Screening Results.
Dang TH, Rieu-Werden ML, Kobrin SC, Tiro JA, Werner C, Lykken JM, Chubak J, Atlas SJ, Higashi RT, Lee SC, Haas JS, Skinner CS, Silver MI, Feldman S. Dang TH, et al. Among authors: silver mi. J Gen Intern Med. 2024 Dec;39(16):3217-3224. doi: 10.1007/s11606-024-08943-z. Epub 2024 Jul 25. J Gen Intern Med. 2024. PMID: 39060782
49 results